The Staphylococcus aureus FnBPA and FnBPB proteins promote acid-induced biofilm accumulation. Meticillin-resistant S. aureus (MRSA) isolates from device-related infections with both fnbA and fnbB produced significantly more biofilm than isolates with either gene alone. Under mildly acidic growth conditions, FnBP-mediated biofilm and fnbA and fnbB transcript levels were substantially higher during growth at 37 6C than at 30 6C. Thus, in addition to a lowered pH, carriage of both fnbA and fnbB and growth at 37 6C promote MRSA biofilm development, further supporting a role for the FnBPA and FnBPB surface proteins in the pathogenesis of MRSA device-related infections.
INTRODUCTION
Since the early 1950s, polymers have been used in the construction of medical devices such as central and peripheral intravascular lines, surgical drains and prosthetic joints (Montdargent & Letourneur, 2000) . Bacteria such as staphylococci that originate from the patient's microflora or exogenously from healthcare personnel or the hospital environment can gain access to the medical device by migration externally from the skin or, as in the case of lines and drains, internally from the catheter hub or port. Occasionally, devices may become haematogenously seeded from another focus of infection. More uncommonly, infusate contamination leads to catheter-related bloodstream infection (O'Grady, 2002) . Guidelines on the prevention of device-related infection therefore focus on (i) education and training of healthcare providers who insert and maintain intravascular lines and drains, (ii) maximal sterile barrier precautions during device insertion and (iii) appropriate skin antisepsis prior to device insertion (O'Grady, 2002) .
Following insertion into the patient, medical devices are rapidly coated with a conditioning film composed primarily of host-derived extracellular matrix proteins. Some of these host proteins can act as receptors for bacterial attachment and can thus play an important role in the early stages of biofilm development (O'Gara, 2007) .
Staphylococcus aureus can bind to a wide range of host matrix proteins, adherence to which is mediated by a group of S. aureus surface proteins termed MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) (Foster & Hook, 1998) . Following this initial attachment to an implanted device, biofilm formation involves a cellular accumulation process. In staphylococci, the exopolysaccharide termed polysaccharide intercellular adhesin or polymeric N-acetylglucosamine (PIA/PNAG) and the surface proteins accumulationassociated protein (Aap), biofilm-associated protein (Bap) and S. aureus surface protein G (SasG) have all been implicated in biofilm accumulation (reviewed by O'Gara, 2007). We recently described a new S. aureus biofilm accumulation phenotype mediated by the multifunctional fibrinogen-and fibronectin-binding proteins FnBPA and FnBPB. FnBP-mediated biofilm development appears to be more commonly associated with meticillinresistant S. aureus (MRSA) isolates than with meticillinsensitive S. aureus (MSSA) isolates (O'Neill et al., 2008) . Furthermore, FnBP-promoted biofilm development by MRSA isolates is triggered by mild acid stress, whereas PIA/PNAG-mediated biofilm development by MSSA isolates is generally induced by osmotic stress (Fitzpatrick et al., 2005; O'Neill et al., 2007 O'Neill et al., , 2008 . FnBP-mediated biofilm development is dependent on the Staphylococcus accessory regulator SarA but not at the level of fnbA and fnbB transcription (O'Neill et al., 2008) .
Here, we examined the relationship between carriage of the fnbA and/or fnbB genes and biofilm-forming capacity in a collection of S. aureus clinical isolates clinically implicated in device-related infection. Furthermore, we examined temperature regulation of FnBP-mediated biofilm formation and fnbA and fnbB transcription in four MRSA isolates.
METHODS
S. aureus strains and growth conditions. The 217 S. aureus isolates (118 MRSA and 99 MSSA) used in this study were from clinically diagnosed, device-related infections collected retrospectively from January 2002 to June 2005. These isolates, which were obtained from a 720-bed tertiary referral centre in Ireland, were collected from blood cultures and line tips, as described previously (O'Neill et al., 2007 (O'Neill et al., , 2008 , and were deemed clinically significant following review by a clinical microbiologist. The genetic background of these isolates was determined previously by sequencing the X-repeat region of the spa gene and performing multilocus sequence typing (MLST) on selected isolates (O'Neill et al., 2007) . The MRSA isolates represented 16 spa types, whereas the MSSA isolates were more genetically diverse and represented 67 spa types. Furthermore, three clones identified by spa types 46, 382 and 781 accounted for 90 % of the MRSA isolates, and all but one of our MRSA isolates for which a clonal complex (CC) could be inferred belonged to CC8 or CC22 (O'Neill et al., 2007) . The previously characterized MRSA isolates (O'Neill et al., 2007 (O'Neill et al., , 2008 BH1CC (SCCmec type II, MLST type 8, CC8), BH3 (SCCmec type II, MLST type 8, CC8), BH4 (SCCmec type II, MLST type 8, CC8) and BH10 (SCCmec type IV, MLST type 22, CC22), which were found to be amenable to genetic manipulation and representative of both CCs in our isolate collection, were used to examine temperature regulation of FnBP-mediated biofilm formation and fnbA and fnbB transcription in this study. S. aureus strains were grown at 30 or 37 uC in brainheart infusion (BHI; Oxoid) medium. BHI broth was supplemented where indicated with 1 % glucose or 4 % NaCl.
Biofilm assays. Semi-quantitative measurements of biofilm formation were determined using tissue culture-treated, 96-well polystyrene plates (Nunclon D surface; Nunc), based on the methods of Christensen et al. (1985) and Ziebuhr et al. (1997) as described previously (O'Neill et al., 2007 (O'Neill et al., , 2008 . Bacteria were grown in individual wells of 96-well plates at 37 uC in BHI medium or BHI medium supplemented with 4 % NaCl or 1 % glucose. After 24 h growth, the plates were washed vigorously. This involved three rounds of plunging the plates into a large volume of distilled water and decanting to remove unattached bacteria. The plates were subsequently dried for 1 h at 60 uC prior to staining with a 0.4 % crystal violet solution. The A 492 of the adhered, stained biofilms was measured using a microtitre plate reader. The laboratory strain RN4220 and its isogenic Dica mutant were used as positive and negative controls, respectively, in all experiments. Biofilm formation by each strain was measured in a minimum of three independent experiments and the mean results are presented. A biofilm-positive phenotype was defined as having an A 492 value ¢0.17.
Genetic techniques. Genomic DNA was prepared as described previously (O'Neill et al., 2008) . PCR with previously described primers (O'Neill et al., 2008) was used to determine the presence or absence of the fnbA and fnbB genes in our 217 clinical isolates. PCRs were carried out using Taq DNA polymerase (Invitrogen) and 3 mM MgCl 2 under the following conditions: 95 uC for 30 s, 54 uC for 30 s and 72 uC for 3 min for 36 cycles. All oligonucleotide primers used for PCR were supplied by MWG-Biotech.
RNA purification, RT-PCR and analysis of RT-PCR data were performed as described previously (O'Neill et al., 2008) on the four well-characterized MRSA isolates. Briefly, following overnight growth in BHI broth, 50 ml bacterial cells was grown in 5 ml BHI broth (supplemented with 1 % glucose) and incubated with shaking (200 r.p.m.) at 37 or 30 uC until the cells reached an OD 600 of 2.0 (exponential phase). The constitutively expressed gyrB gene was used as an internal standard in these experiments using the primers described by Goerke et al. (2000) . The following primer sets were used: for fnbA, SAfnbAFOR (59-CGCGGATCCGGTACAGATGT-AACAAGTAAAG-39) and SAfnbAREV (59-GACGCGTCGACTT-AATTCGGACCATTTTTCTCATT-39); for fnbB, SAfnbBFOR (59-CGCGGATCCGTGGAAGTAGAAGAAGGTAG-39) and SAfnbAREV (59-GACGCGTCGACTTAATTAGGTTCCTT-TAGTTTATC-39); and for gyrB, SAgyrBFOR (59-TTATGGTGCTGGGCAAATACA-39) and SAgyrBREV (59-CACCATGTAAACCACCAGATA-39). Reverse transcription was performed at 50 uC for 30 min, terminated at 94 uC for 15 min and followed by 20 cycles of PCR for gyrB and up to 30 cycles of PCR for fnbA and fnbB amplification.
RESULTS AND DISCUSSION
Relationship between carriage of the fnbA and fnbB genes and biofilm-forming capacity in S. aureus clinical isolates Mutation of the S. aureus fnbA and fnbB genes is accompanied by loss of glucose-induced biofilm development in MRSA isolates (O'Neill et al., 2008) . Growing S. aureus in BHI medium with 1 % glucose lowers the final culture pH to 5 compared with approximately 8.5 in BHI medium without glucose, and this mildly acidic pH correlates with induction of FnBP-promoted biofilm (O'Neill et al., 2008) . In addition, the expression of either the fnbA or fnbB gene on multicopy plasmids can independently promote biofilm development in both MRSA and MSSA clinical isolates (O'Neill et al., 2008) , suggesting that the FnBPA and FnBPB proteins can substitute functionally for each other and that expression of both proteins may enhance biofilm-forming capacity. To investigate this possibility, we examined the correlation between the rate of fnbA and fnbB carriage and the mean biofilm-forming capacity in BHI medium supplemented with 1 % glucose in our previously described collection of 217 clinical MRSA (n5118) and MSSA (n599) isolates (O'Neill et al., 2007) . PCR demonstrated that 40/118 (34 %) of the MRSA isolates possessed both fnbA and fnbB compared with 68/99 (69 %) of the MSSA isolates (Table 1) . Of the MRSA isolates, 77/118 (65 %) were positive for the fnbA gene alone compared with 19/99 (19 %) of the MSSA isolates, while only 1/118 (0.9 %) of the MRSA isolates and 8/99 (8 %) of the MSSA isolates were positive for fnbB alone. None of our MRSA clinical isolates and only 4/99 (4 %) of our MSSA isolates lacked both the fnbA and fnbB genes.
Carriage of both the fnbA and fnbB genes together was associated with a significantly higher level of biofilm production in MRSA isolates than carriage of either gene alone (P ,0.0001, Student's t-test) (Fig. 1) . Similarly, MSSA isolates possessing either the fnbA or fnbB gene alone were capable of significantly higher levels of acidinduced biofilm production than MSSA isolates lacking both genes (P50.01, Student's t-test) (Fig. 1) . However, unlike MRSA, MSSA isolates with both the fnbA and fnbB genes did not form significantly more acid-induced biofilm than isolates with either gene alone (P50.78, Student's ttest) (Fig. 1) , suggesting a less important role for the FnBPs in MSSA biofilm development. However, as observed in MRSA isolates (O'Neill et al., 2008) , expression of fnbA or fnbB from multicopy plasmids dramatically increased acidinduced biofilm development in a number of MSSA isolates (O'Neill et al., 2008) . These findings indicate that acid-induced, FnBP-mediated biofilm development is more commonly associated with MRSA isolates and that carriage of both the fnbA and fnbB genes, as opposed to either gene alone, is associated with significantly higher levels of biofilm production. In this context, it is interesting to note that, similar to their ligand-binding activity, the fnbA and fnbB genes could functionally substitute for each other as biofilm adhesins and that expression of both proteins may enhance biofilm-forming capacity.
In contrast, MSSA isolates with both genes did not form more acid-induced biofilm than isolates with either gene alone, although FnBPA and FnBPB may contribute to the MSSA biofilm phenotype under appropriate environmental conditions.
Regulation of FnBP-mediated biofilm development in S. aureus
The staphylococcal biofilm phenotype is tightly regulated and highly responsive to environmental conditions. As described above, FnBP-mediated biofilm development is induced by mild acid stress and, unlike PIA/PNAGpromoted biofilm, is unaffected by osmotic stress in medium supplemented with NaCl (O'Neill et al., 2008) . To investigate further the conditions that influence FnBPmediated biofilm formation, we examined the impact of temperature on this phenotype in four previously characterized MRSA isolates, BH1CC, BH3, BH4 and BH10 (O'Neill et al., 2007 (O'Neill et al., , 2008 . BH1CC, BH3, BH4 and BH10 possess both fnbA and fnbB and produce FnBP-mediated biofilm (O'Neill et al., 2007 (O'Neill et al., , 2008 . These experiments revealed that mild acid-induced biofilm formation was significantly reduced at 30 u C compared with 37 u C (P ,0.001, Student's t-test) (Fig. 2a) . Transcript levels of fnbA and fnbB in all four isolates were then measured using RT-PCR. Transcript levels of fnbA and fnbB were very low, necessitating up to 30 cycles of PCR compared with 20 amplification cycles for the gyrB housekeeping gene, possibly suggesting that transcriptional regulation of fnbA and fnbB does not play an important role in controlling FnBP-mediated biofilm. Nevertheless, expression of fnbB was measurably higher at 37 u C than at 30 u C in all four strains (Fig. 2b) . Similarly, transcript levels of fnbA were also higher at 37 u C in three of the four MRSA strains tested (Fig. 2b) .
The data presented in this study indicate that carriage of both fnbA and fnbB and growth at 37 u C correlate with enhanced acid-induced biofilm development in MRSA clinical isolates. However, it remains unclear whether temperature significantly influences FnBP-mediated biofilm formation at the level of fnb gene expression. We reported previously that FnBP-mediated MRSA biofilm was SarA-dependent, even though mutation of sarA was not accompanied by reduced fnbA or fnbB transcription (O'Neill et al., 2008) . SarA controls expression of the four major extracellular proteases in S. aureus and we also demonstrated that BH1CC, BH3, BH4 and BH10 biofilms were dispersed following treatment with exogenous V8 protease (O'Neill et al., 2008) . It therefore also seems possible that altered MRSA cell-surface characteristics at different growth temperatures may indirectly influence the ability of the cell-wall-anchored FnBPs to promote biofilm formation. 
